Skip to main content

Cost-efficient European adaptations of global health economic models

Experience with model adaptations in Austria, Belgium, France, Germany, Italy, Norway, Netherlands, Spain, Sweden, the UK

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

The G-BA Innovation Committee recommends transfer to standard care for another three projects in Germany

On February 23, 2023, the Innovation Committee at the Federal Joint Committee (G-BA) published the decisions, recommending the transfer to standard care for another three completed projects. The projects relate to preventing the family risk of colorectal carcinoma, shared decision-making in the hospitals, and digitally supported drug therapy management.

The “FARKOR – Prevention in family risk of colorectal carcinoma” project tested various access routes to identify people with a family history of increased risk of colorectal cancer to be able to offer them an immunochemical fecal occult blood test (iFOBT) or a colonoscopy as an early detection test. In addition, detection rates and the distribution of stages of colorectal cancer were collected from the people examined and linked to routine data. It was also possible to make a statement on the frequency of participation and influencing factors. With the help of the FARKOR project, a strategy for the early detection of colorectal cancer was developed and evaluated, aimed at people aged 25 to 50 with a family history of increased risk.

The “MAKING SDM A REALITY – full implementation of shared decision making in the hospital” project combined various measures to successfully anchor shared decision-making (SDM) in everyday clinical practice: training modules for physicians and other health professionals, a campaign to activate patients and 80 newly developed, scientifically based online decision-making tools.

In the “AdAM - Application of digitally supported drug therapy and care management” project, the introduction of digitally supported drug therapy management was tested at the participating general practitioners' practices: practices can be supported in recognizing medication and dosage risks better and faster.

The detailed results of the projects are now being forwarded to the relevant organizations and institutions in the healthcare sector. In this regard, the respective stakeholders are requested to review the results and consider them within their area of responsibility as much as possible, specifically concerning the quality assurance aspect.

The full details in German can be found here, here (the decision and the results of the FARKOR project), here (the decision and the results of the MAKING SDM A REALITY project), and here (the decision and the results of the AdAM project).

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Contact us to get a free, three-month, no-obligation trial.